International Cancer Conference Journal

, Volume 6, Issue 2, pp 70–75 | Cite as

Ascending colon cancer coincident with mesenteric phlebosclerosis associated with the long-term oral intake of Chinese herb containing gardenia fruit: A case report and literature review

  • Kazuhito Minami
  • Masashi Fujiie
  • Fumiyoshi Fushimi
  • Kenichi Taguchi
  • Yosinari Nobutoh
  • Daisuke Yoshida
  • Mituhiko Ota
  • Masahiko Ikebe
  • Masaru Morita
  • Yasushi Toh
Case report
  • 55 Downloads

Abstract

Mesenteric phlebosclerosis is a recently discovered rare ischemic colon disease. The relationship between mesenteric phlebosclerosis and the use of herbal medicine containing gardenia fruit was recently reported. Although the relationship between colon cancer and mesenteric phlebosclerosis has not been described, some cases of colorectal cancer coincident with mesenteric phlebosclerosis have been reported. We treated a 63-year-old female who was diagnosed with ascending colon cancer coincident with mesenteric phlebosclerosis. She had been taking a Chinese herb containing gardenia fruit for over 18 years. The ascending colon cancer was clinically diagnosed as T2, N0, and M0 according to Japanese classification of colorectal carcinoma and the mesenteric phlebosclerosis had spread from the cecum to the descending colon. She underwent laparoscopic subtotal colectomy with en bloc removal of the regional lymph nodes, and both the ascending colon cancer and mesenteric phlebosclerosis were completely resected. The microscopic findings show that the tumor was well-differentiated tubular adenocarcinoma invading the muscular propria with no regional lymph node metastasis, and the mesenteric phlebosclerosis lesion was characterized by marked fibrous thickening of the venous walls with calcification, marked transmural fibrosis and deposition of the collagen in the mucosa, accompanied by macrophages within the vessel walls. In literature review, 10 cases with colorectal cancer coincident with mesenteric phlebosclerosis were reported. 9 of 10 cases (90%) had cancer in the right-side colon affected by mesenteric phlebosclerosis, and 5 of 10 cases (50%) were associated with the use of a Chinese herb containing gardenia fruit. It was recently demonstrated that genipin, which is a metabolite bio-transformed from gardenia fruit, possesses carcinogenesis. We speculate that genipin may be associated with not only the development of mesenteric phlebosclerosis but also carcinogenesis in the right-side colon. In conclusion, our findings suggest that the safety of gardenia fruit should be re-evaluated, and gastroenterologists should be aware that gardenia fruit may be risk factor for not only the development of mesenteric phlebosclerosis but also carcinogenesis in the proximal colon.

Keywords

Colon cancer Mesenteric phlebosclerosis Chinese herb Gardenia fruit (sanshishi) Genipin 

Notes

Acknowledgements

The authors thank Dr. Brian Quinn for assistance in editing the manuscript.

Compliance with ethical standards

Conflict of interest

All authors have no conflict of interest to disclose.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Written informed consent was obtained from the patient for the publication of this case report and any accompanying images.

References

  1. 1.
    Koyama N, Koyama H, Hanajima T et al (1991) Chronic ischemic colitis causing stenosis: report of a case. Stomach Intest 26:455–456 (Japanese with English abstract) Google Scholar
  2. 2.
    Iwashita A, Takemura S, Yamada Y et al (1993) Pathomorphologic study on ischemic lesions of the small and large intestine. Stomach Intest 28:927–941 (Japanese with English abstract) Google Scholar
  3. 3.
    Oshitani N, Matsumura Y, Kono M et al (2002) Asymptomatic chronic intestinal ischemia caused by idiopathic phlebosclerosis of mesenteric vein. Dig Dis Sci 47:2711–2714CrossRefPubMedGoogle Scholar
  4. 4.
    Kusanagi M, Matsui O, Kawashima H et al (2005) Phlebosclerotic colitis: imaging-pathologic correlation. Am J Roentgenol 185:441–447CrossRefGoogle Scholar
  5. 5.
    Guo F, Zhou YF, Zhang F et al (2014) Idiopathic mesentericphlebosclerosis associated with long-term use of medical liquor: two casereports and literature review. World J Gastroenterol 20:5561–5566CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Shimizu S, Kobayashi T, Tomioka H et al (2016) Involvement of herbal medicine as a cause of mesenteric phlebosclerosis: results from a large-scale nationwide survey. J Gastroenterol 51:1–7CrossRefGoogle Scholar
  7. 7.
    Shimizu K, Nishimura Z, Mitida T et al (2000) A case of ischemic intestinal lesion caused by phlebosclerosis without clinical symptoms for three years. J Colon Exam 17:192–195 (Japanese) Google Scholar
  8. 8.
    Kimura Y, Kashima K, Daa T et al (2003) Phlebosclerotic colitis coincident with carcinoma in adenoma. Pathol Intl 53:721–725CrossRefGoogle Scholar
  9. 9.
    Ota A, Iwashita A, Ikeda K et al (2009) Idiopathic mesenteric phlebosclerosis coincident with adenocarcinoma of the ascending colon, report of a case. Stomach Intest 44(2):227–232 (Japanese with English abstract) Google Scholar
  10. 10.
    Yamaoku K, Saeki H, Katayama Y et al (2011) A case report on idiopathic mesenteric phlebosclerosis accompanied by carcinoma of the transverse colon. J Jpn Coll Surg 36(6):1020–1026 (Japanese with English abstract)Google Scholar
  11. 11.
    Hiramatsu K, Sakata H, Horita Y et al (2012) Mesenteric phlebosclerosis associated with long-term oral intake of geniposide, an ingredient of herbal medicine. Aliment Pharmacol Ther 36:575–586CrossRefPubMedGoogle Scholar
  12. 12.
    Komori T, Kato A, Chono A et al (2012) Idiopathic mesenteric phlebosclerosis with ascending colon cancer—a case report. J Jpn Soc Coloproctol 65:124–129 (Japanese with English abstract) CrossRefGoogle Scholar
  13. 13.
    Omoto T, Tanaka J, Takayanagi D et al (2013) Idiopathic mesenteric phlebosclerosis with transverse colon cancer—a case report (in Japanese). The 68th general meeting of the Japanese Society of Gastroenterological SurgeryGoogle Scholar
  14. 14.
    Yamazi K, Sumi K, Tanaka S et al (2014) Mesenteric phlebosclerosis coincident with adenocarcinoma of the cecum: a case report. Rinsho Geka 8:1003–1008 (Japanese) Google Scholar
  15. 15.
    Tani C, Asai K, Miyamoto M et al (2014) A case of idiopathic mesenteric phlebosclerosis with ascending colon cancer treated with laparoscopic colectomy (in Japanese). The 69th annual meeting of the Japan Society of Coloproctology.Google Scholar
  16. 16.
    Ozaki A, Kitano M, Furusawa N et al (2002) Genotoxicity of gardenia yellow and its components. Food Chem Toxicol 40:1603–1610CrossRefPubMedGoogle Scholar
  17. 17.
    Khanal T, Kim HG, Do MT et al (2014) Genipin induces cyclooxygenase-2 expression via NADPH oxidase, MAPKs, AP-1, and NF-κB in RAW 264.7 cells. Food Chem Toxicol 64:126–134CrossRefPubMedGoogle Scholar
  18. 18.
    Japanese Society for Cancer of the Colon and Rectum (2013) Japanese Classification of Colorectal Carcinoma (Eighth Edition). Kanehara & Co., Ltd., TokyoGoogle Scholar
  19. 19.
    Japanese Society for Cancer of the Colon and Rectum (2014) Guidelines for the treatment of colorectal cancer. Kanehara & Co., Ltd., TokyoGoogle Scholar
  20. 20.
    Kang MJ, Khanal T, Kim HG et al (2012) Role of metabolism by human intestinal microflora in geniposide-induced toxicity in HepG2 cells. Arch Pharm Res 35:733–738CrossRefPubMedGoogle Scholar
  21. 21.
    Nagata Y, Watanabe T, Nagasaka K et al (2016) Clinical Search for undiagnosed mesenteric phlebosclerosis at outpatient Departments Specializing in Herbal (Kampo) Medicine. Intern Med 55:573–581CrossRefPubMedGoogle Scholar
  22. 22.
    Nagata Y, Watanabe T, Nagasaka K et al (2016) Total dosage of gardenia fruit used by patients with mesenteric phlebosclerosis. BMC Complement Altern Med 16:207CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    AkaoT, Kobayashi K, Aburada M et al (1994) Enzymic studies on the animal and intestinal bacterial metabolism of geniposide. Biol Pharm Bull 17(12):1573–1576CrossRefGoogle Scholar
  24. 24.
    Papagiorgis PC, Oikonomakis I, Delaportas D et al (2014) Proximal shift of colorectal cancer. A persistent phenomenon with multiple causes, patterns and clinical implications. J BUON 19(3):605–617PubMedGoogle Scholar
  25. 25.
    Shibutani S, Takeshita M, Grollman AP et al (1991) Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature 349:431–434CrossRefPubMedGoogle Scholar
  26. 26.
    Wang D, Dubois RN (2010) Eicosanoids and cancer. Nat Rev Cancer 10:181–193CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© The Japan Society of Clinical Oncology 2017

Authors and Affiliations

  • Kazuhito Minami
    • 1
  • Masashi Fujiie
    • 2
  • Fumiyoshi Fushimi
    • 3
  • Kenichi Taguchi
    • 3
  • Yosinari Nobutoh
    • 1
  • Daisuke Yoshida
    • 1
  • Mituhiko Ota
    • 1
  • Masahiko Ikebe
    • 1
  • Masaru Morita
    • 1
  • Yasushi Toh
    • 1
  1. 1.Department of Gastroenterological SurgeryNational Kyushu Cancer CenterFukuokaJapan
  2. 2.Department of SurgeryFukuoka Wajiro HospitalFukuokaJapan
  3. 3.Department of Diagnostic PathologyNational Kyushu Cancer CenterFukuokaJapan

Personalised recommendations